NCT02035527 2018-05-24Sorafenib Tosylate, Cisplatin, and Docetaxel in Treating Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckOhio State University Comprehensive Cancer CenterPhase 1 Completed3 enrolled